Current practice and awareness of pediatric off-label drug use in Shanghai, China -a questionnaire-based study

Abstract

Background Off-label drug use is widespread in pediatric drug treatment, and the implementation of guidelines on this topic remains challenging. The objective of this study was to evaluate current practice and awareness of healthcare professionals towards pediatric off-label drug use, as well as the barriers to guideline implementation among pediatric healthcare professionals in Shanghai, China. Methods A validated questionnaire was issued to representatives of pediatricians, pharmacists, nurses and administrators from hospitals with pediatric qualification in Shanghai. Results A total of 679 completed questionnaires from 69 hospitals were included in the analysis. Nearly half (47.9%) of the pediatricians acknowledged that they had prescribed off-label drugs. Most (88.4%) of the pharmacists acknowledged that they had dispensed off-label medicines. The main reason for off-label prescribing was the lack of pediatric dosage information. The most common category of off-label prescribing in children was dosage. Nearly half (42.0%) of the participating hospitals had developed internal protocols for off-label drug use. However, approximately half of the respondents reported that they did not adhere to the guidance and that it had barriers to implementation. Most respondents (84.5%) declared that they were familiar with the term “off-label drug use”. However, the awareness rate of the Chinese Expert Consensus of Pediatric Off-Label Drug Use was low (45.7%). More than half (55.4%) of the respondents declared that they did not adhere to the process proposed in the consensus and that barriers existed for its utilization. Conclusions Pediatric off-label drug use is widespread in Shanghai, China, and barriers exist to the implementation of the guideline. A legally recognized national guideline with a broad scope of application for off-label drug use is urgently needed; at the same time, more education and training on off-label drug use should be provided to targeted healthcare professionals. Electronic supplementary material The online version of this article (10.1186/s12887-019-1664-7) contains supplementary material, which is available to authorized users.

Point-of-care training program on COVID-19 infection prevention and control for pediatric healthcare workers

“…Tables Table 1 Demographics and professional *HCW in China are often classified as "senior", "middle" or "junior" grade according to their skill levels and specialization. For example, doctors with senior title refer to chief physician or associate chief physician, middle grade refer to attending physicians and junior title refer to residents [11] . Table 3 Each item concerned, category and the accuracy of the answers…”

“…As a descriptive study, a minimum sample size of 328 was required taking into account the expected accuracy of the questionnaire to be > 95% with total width of the con dence interval of 5%. To ensure at least 3 samples within each stratum of three professionals for 81 hospitals, a total of 729 participants were required in this study to meet the calculated minimum sample size [11] . The demographic characteristics of the participants were described as n (%),%), and the scores were described as median with IQR.…”

<p>Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations</p>

“…The main physiologic and pharmacokinetic variation between pediatrics and adults include the rate of gastric emptying and pH of the GIT, gastrointestinal permeability, the surface area available for drug absorption and distribution, hepatic and renal function, and the elimination process. 12 The largest difference from adult pharmacokinetics occurrs during the first 12-18 months since organ functions are still developing. 13 A number of anatomical and physiological factors determine the pharmacokinetic profile of a drug.…”

“…Gastrointestinal (GI) upset which caused by ethanol is also more pronounced in children than other populations. 12 Pediatric patients are more vulnerable to the effects of ethanol, especially in the younger age groups of less than 6 years. Higher peak ethanol blood concentrations are observed in children compared to adults for similar intake.…”

General Characteristics and Quality Assessment of Pediatric Randomized Controlled Trials Published in Mainland China over the Decades 1999-2018

“…Due to lack of sufficient information on children's medication in the drug labels, off-label prescribing is widespread worldwide. Studies showed the prevalence of off-label prescribing in children was from 28.3 to 46.5% [1][2][3][4] , and probably more common in China [5,6] , thus, higher risks related to treatment and legal exist in the treatment of children's diseases [7] . In addition to the drug labels, clinical treatment guidelines and expert consensuses based on clinical research have become the main sources and basis of physicians' medication evidence [8,9] , especially pediatricians, and the clinical research evidence in the guidelines and expert consensuses generally graded according to the research design type.…”